SMG heads into its July 29 earnings report with short sellers quietly adding pressure and the options market leaning bullish — a divergence that makes the setup more interesting than the flat weekly price action suggests.
The short position is the most notable development this week. At 10% of free float, SMG's short interest is meaningfully elevated, and it has been building steadily — up 6.5% over the past week and nearly 7% over the past month. That puts shares short at approximately 5.81 million, the highest level in the 30-day window tracked here. The ORTEX short score reinforced that tone on Tuesday, jumping to 64.4 from 61.8 at the start of the week — a two-point move that accelerates a trend running since late June. Yet the borrow market tells a more relaxed story. Cost to borrow is just 0.51%, barely above the 30-day floor, and availability is running at roughly 311% — meaning there are more than three times as many shares available to lend as are currently borrowed. Bears can still open positions cheaply and easily, which removes any near-term mechanical squeeze pressure. Positioning looks bearish in direction but not crowded in execution.
Options traders are reading the situation differently. The put/call ratio has pulled back to 0.49, well below its 20-day average of 0.58 and sitting in the lower half of the year's range. That tilt toward calls reflects more demand for upside exposure than has been typical in recent weeks — a quiet vote of confidence from the derivatives market that contrasts with the short-interest build. The z-score of -0.65 is not dramatic, but the directional shift from the June pattern is real: PCR averaged closer to 0.72 through most of last month before dropping sharply in late June.
The Street's view is similarly mixed, though the freshest signal leans positive. Wells Fargo raised its price target on SMG to $74 this morning — moving above the current $66.79 close — while reiterating Overweight. That follows a target trim from Stifel in early June, which kept its Buy but pulled its number from $76 to $75. The consensus mean sits near $72.67, implying modest upside from current levels. Bulls point to the US consumer segment's underlying demand and the scope for margin recovery. Bears flag projected revenue softness — US consumer revenue expected down around 1% for FY25 — alongside commodity volatility and a still-leveraged balance sheet. The EV/EBITDA multiple has crept up about 0.08x over the past month to roughly 10.5x, nudging the valuation conversation into less comfortable territory for value-focused holders. The dividend score ranks in the 98th percentile, though the dividend history in the data is stale, suggesting any income angle should be treated cautiously.
One ownership detail stands out from the institutional picture. Hagedorn Partnership LP, the founding family vehicle, remains the dominant holder at 22.6% of shares. It trimmed 50,000 shares in February — a $3.3 million sale at around $66.40. That price is almost exactly where SMG trades today, meaning the founding family sold near current levels earlier this year. Ariel Investments entered or rebuilt a position in Q1, adding 962,642 shares. BlackRock added 235,875 shares through June 30. The buying from passive and active managers partially offsets the family reduction, but the seller profile is worth noting.
The last earnings print, on April 29, sent SMG down 4.1% in a single session and left it 3.9% lower five days later. With July 29 now three weeks out, the convergence of a rebuilding short position, a freshly raised Wells Fargo target, and a put/call ratio running well below trend makes the next few weeks worth watching closely — particularly any guidance language around FY25 US consumer volumes and leverage trajectory.
See the live data behind this article on ORTEX.
Open SMG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
